Pharmaceutical Gelatin Market to Grow with a CAGR of 5.51% through 2030
Increasing healthcare infrastructure and a
supportive regulatory environment, is expected to drive the Global
Pharmaceutical Gelatin Market growth in the forecast period, 2026-2030
According to
TechSci Research report, “Pharmaceutical Gelatin Market – Global Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2030F”,
the Global Pharmaceutical Gelatin Market stood at USD 1.89 Billion in
2024 and is expected to reach USD 2.61 Billion by 2030 with a CAGR of 5.51% during
the forecast period. This can be due to collaborations and
partnerships among leading companies with a diverse approach to merge the
expertise of individual companies and to strengthen their position in the
market. The
shift towards nutraceuticals has been a significant driver of the demand for
pharmaceutical gelatin. Nutraceuticals are products that combine the benefits
of nutrition and pharmaceuticals, often in the form of dietary supplements,
vitamins, and functional foods. Gelatin capsules, including soft gel capsules,
are a popular choice for encapsulating vitamins, minerals, herbal extracts, and
other nutraceutical ingredients. These capsules provide an effective and
convenient way to deliver these substances to consumers. Gelatin capsules are
easy to swallow, making them suitable for consumers of all ages, including
those who may have difficulty swallowing large tablets or pills. This ease of
administration enhances consumer compliance and satisfaction. Gelatin is known
for its digestibility, which is important for nutraceutical products intended
to support digestive health. Gelatin-based capsules are gentle on the stomach
and aid in the efficient absorption of nutrients. Gelatin capsules can
effectively mask the taste and odor of certain nutraceutical ingredients, which
may have strong or unpleasant flavors. This makes the consumption of these
supplements more palatable for consumers. Gelatin capsules can be easily
customized in terms of size, color, and appearance, allowing nutraceutical companies to differentiate their products and meet specific consumer
preferences. Gelatin helps protect the stability and integrity of sensitive
nutraceutical ingredients, including vitamins and antioxidants, by acting as a
protective barrier against environmental factors such as moisture and oxygen. Gelatin
used in nutraceuticals must meet regulatory standards for safety and quality.
Manufacturers rely on pharmaceutical-grade gelatin to ensure compliance with
these standards. Many consumers prefer gelatin-based capsules for their
nutraceutical supplements due to familiarity and confidence in the quality and
safety of these dosage forms.
In May 2022, Lonza has enhanced its Capsugel range by introducing a white hard gelatin capsule that does not contain titanium dioxide (TiO2). This addition is a response to the changing requirements of customers who seek TiO2-free options for food products in compliance with European Union regulations. This innovative opacifying technology utilizes crystallized salts to achieve the same level of whiteness and masking as capsules containing TiO2. In an internal comparative study, Lonza's alternative to TiO2 demonstrated excellent light protection and opacity when compared to other TiO2 alternatives and capsules that include TiO2.
Competition from alternatives is a challenge in the global pharmaceutical gelatin market. This challenge arises from the growing interest in and development of alternative ingredients and formulations that aim to replace or reduce the reliance on traditional pharmaceutical-grade gelatin. One of the most notable alternatives to animal-derived gelatin is plant-based gelatin, often referred to as "vegan gelatin" or "gelatin substitutes." Plant-based alternatives are typically derived from sources like seaweed (agar-agar), pectin, or starches. These alternatives are gaining popularity among consumers who follow vegan or vegetarian diets or seek cruelty-free options. Researchers have also explored the use of microbial fermentation to produce gelatin-like proteins without the need for animal sources. Microbial-derived gelatin alternatives are considered more sustainable and ethical and are being investigated for various applications. Some companies are developing modified versions of traditional gelatin to enhance its properties or address specific formulation needs. These modifications may include cross-linking, chemical modifications, or combinations with other polymers. Hydrocolloids like carrageenan, xanthan gum, and guar gum are used as gelling agents and thickening agents in pharmaceutical formulations. They offer alternatives to gelatin for specific applications.
Browse
over XX market data Figures and spread through XX Pages and an in-depth TOC on
"Global Pharmaceutical Gelatin Market”
The Global Pharmaceutical
Gelatin Market is segmented into type,
source, function, end user, regional distribution, and company.
Based on the End
User, Soft Capsule emerged as the fastest growing segment in the Global Pharmaceutical
Gelatin Market during the forecast period. This is due to their increasing adoption across
both prescription and over-the-counter pharmaceutical products. Soft gelatin
capsules offer several advantages, such as improved patient compliance, ease of
swallowing, and enhanced bioavailability of poorly water-soluble drugs. Their
ability to encapsulate both hydrophilic and lipophilic substances makes them a
preferred drug delivery format, especially for complex formulations and dietary
supplements. Pharmaceutical companies are increasingly focusing on soft gelatin
capsules to meet the growing demand for personalized and patient-centric dosage
forms. The surge in the use of nutritional supplements and the expansion of the
geriatric population, who often face difficulties swallowing traditional
tablets, are further propelling the demand for soft capsules.
Based
on the Region, Asia-Pacific emerged as the fastest growing region in the Global
Pharmaceutical Gelatin Market during
the forecast period. This is due to the rising geriatric population and the
increasing burden of chronic illnesses, which are propelling the demand for
easily consumable and bioavailable dosage forms such as softgel capsules. In
addition, the booming nutraceutical and dietary supplement industries in
countries like China, India, and Indonesia are fueling demand for gelatin-based
products. With a growing middle-class population and increasing disposable
income, consumers are becoming more inclined toward preventive healthcare and
wellness supplements, many of which rely on pharmaceutical-grade gelatin for
delivery. The rise in clinical research activities, along with local
investments in R&D for gelatin alternatives and enhanced formulations, is
also accelerating market growth. Local suppliers are increasingly forming
partnerships with international pharmaceutical and nutraceutical brands to meet
the surging demand, improving both capacity and quality standards. This dynamic
environment positions Asia-Pacific as the fastest expanding regional market,
supported by an ecosystem that blends innovation, demand, and large-scale
manufacturing capabilities.
Some
of the major companies operating in the Global
Pharmaceutical Gelatin Market include:
- Gelita
AG
- Trobas
Pharmaceutical gelatine B.V
- Rousselot
SAS
- Gelatines
Weishardt SAS
- Sterling
Biotec Ltd.
- Catalent,
Inc
- Nitta
Pharmaceutical Gelatin India Limited
- Aspire
Pharmaceuticals
- Gelco
International
Download Free Sample Report
Customers can also request 10% free
customization on this report
“The Global Pharmaceutical Gelatin Market
is expanding due to the growing focus on clean-label and allergen-free
products, as consumers increasingly demand transparent and safe ingredients in
their medications and supplements. Pharmaceutical companies are responding by
using high-quality, non-GMO gelatin sourced from controlled environments to meet
these consumer preferences. Gelatin's versatility and compatibility with
various formulations, combined with the increasing trend of natural and organic
products, are making it a preferred choice for manufacturers. This shift
towards clean-label products, alongside the growing interest in plant-based
alternatives, is creating new opportunities in the market.,”
said Mr. Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“Pharmaceutical Gelatin
Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,
Segmented By Type (Type A, Type B), By Source (Porcine, Bovine Skin, Bovine
Bone, Fish, Poultry), By Function (Stabilizing, Thickening, Gelling, Others),
By End User (Hard Capsule, Soft Capsule, Tablet, Absorbable Hemostat, Others),
By Region and Competition, 2020-2030F”, has evaluated
the future growth potential of Global Pharmaceutical Gelatin Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Pharmaceutical Gelatin Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com